For US residents only | For US health care professionals
iStock-1007232098

How can my patients receive Metopirone®?

HRA Pharma Rare Diseases is committed to providing the highest level of pharmacy services through its relationship with Walgreens Specialty Pharmacy.

How to prescribe:

Call, fax or e-scribe your prescriptions to Walgreens Specialty Pharmacy.

Call: 1-800-320-2112
Fax: 1-866-889-1510
e-scribe: search Walgreens Specialty Pharmacy

Walgreens Specialty Pharmacy Prescription Form – Metopirone

How do I e-prescribe to Walgreens Specialty Pharmacy for specialty medicines?

To provide the best access possible, our central specialty pharmacies are located in key regions across the country. While some restrictions may apply, you can usually send the prescription to whichever location listed below is closest to your patient. The preferred site for Metopirone (metyrapone) is the Pittsburgh central specialty location.
If you are unsure where to send a prescription to, please call us at 855-244-2555.

Walgreens Specialty Pharmacy – PENNSYLVANIA
Pittsburgh, PA
130 Enterprise Drive
Pittsburgh, PA 15275
Phone: 888-347-3416
Fax: 877-235-9807

WSP_Sub-Brand-Logo_RGB_transparent-background-e1722260617838

Hospital and Institutional orders

For hospital and institutional orders, contact  Direct Success, Inc. at
1-844-597-6373 or Distribution@DSuccess.com.

INDICATION AND IMPORTANT SAFETY INFORMATION

READ MORE ⇧

Metopirone® is indicated, in combination with other diagnostic tests, for the diagnosis of adrenal insufficiency in adult and pediatric patients.

Metopirone® is contraindicated in patients with adrenal cortical insufficiency, or hypersensitivity to Metopirone® or to any of its excipients.

Metopirone® may induce acute adrenal insufficiency. Ability of adrenals to respond to exogenous ACTH should be demonstrated before Metopirone® is employed as a test. In the presence of hypo- or hyperthyroidism, response to the Metopirone® test may be subnormal.

Since Metopirone® may cause dizziness and sedation, patients should not drive or operate machinery until these effects have passed.

The following adverse reactions have been observed after use of Metopirone®: hypotension, nausea, vomiting, abdominal discomfort or pain, headache, dizziness, sedation, allergic rash, leukopenia, anemia, and/or thrombocytopenia.

Avoid concomitant use with acetaminophen. Anticonvulsants, psychotropic, hormone preparations, corticosteroids, antithyroid agents, and cyproheptadine may affect the results of the Metopirone® test.

Please see Full Prescribing Information for METOPIRONE® (metyrapone) capsules. To report SUSPECTED ADVERSE REACTIONS, contact Direct Success Pharmacy, Inc. at 1-844-597-6373 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

HRA Pharma Rare Diseases, 200 avenue de Paris, 92320, Chatillon, FRANCE
Tel: +33 (0) 1 40 33 93 14 / Fax: +33 (0) 1 40 33 30 87
© 2020 HRA Pharma Rare Diseases | Metopirone is a registered trademark of HRA Pharma Rare Diseases
Privacy Notice | Cookie Statement
Last updated: June 2023; MTP – US – 0028

You are now leaving Metopirone.us

Metopirone.us provides links to web sites of other organizations in order to provide visitors with certain information. A link does not constitute an endorsement of content, viewpoint, policies, products or services of that web site. Once you link to another web site not maintained by Metopirone.us, you are subject to the terms and conditions of that web site, including but not limited to its privacy policy.

You will be redirected to

Click the link above to continue or CANCEL